Dr. O'reilly On Nab-Paclitaxel Plus Gemcitabine Vs Folfirinox

Dr. O'Reilly on Nab-Paclitaxel Plus Gemcitabine Vs FOLFIRINOX

Eileen M. O'Reilly, MD: The Nab-Paclitaxel/Gemcitabine Regimen in Frontline Standard of Care

Targeted Oncology

Tarextumab in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer

Targeted Oncology

Dr. Ramanathan on Gemcitabine/Nab-Paclitaxel Followed by mFOLFIRINOX in Pancreatic Cancer

SEQUENCE: nab-paclitaxel/gemcitabine with modified FOLFOX in pancreatic cancer

JCOG1611: nab-paclitaxel/gemcitabine vs. FOLFIRINOX/S-IROX in met or recurrent pancreatic cancer

Perioperative chemotherapy with mfolfirinox vs gemcitabine/nab-paclitaxel for resectable pancrea...

Adjuvant Therapy in Locally Advanced Pancreatic Cancer

Frontline Options for the Treatment of Pancreatic Cancer

Targeted Oncology

Metastatic cancer: Nab -paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy

Alexandros G. Sfakianakis

Nab-Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer

Dosing Options With Nab-Paclitaxel/Gemcitabine

Advanced Pancreatic Cancer: Deciding Among Frontline Standards of Care

Debate 9: Optimal Adjuvant Therapy in Pancreatic Cancer? - Intensified chemotherapy

Sequencing Strategies in Metastatic Pancreatic Cancer

Schedules for Gemcitabine, Nab-Paclitaxel for Pancreatic Cancer

Dr. Saab on Napabucasin With Gemcitabine and Nab-Paclitaxel in Pancreatic Adenocarcinoma

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer

Dr. Ramesh Ramanathan on Nab-Paclitaxel Plus Gemcitabine in Pancreatic Cancer

GAP study: nab-paclitaxel & gemcitabine in locally advanced, unresectable pancreatic cancer